Back to User profile » Dr Hao Ding
Paper published by Dr Hao Ding:
Case report
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report
Zhao Y, Chen Y, Huang H, Li X, Shao L, Ding H
OncoTargets and Therapy 2021, 14:3063-3067
Published Date: 7 May 2021